MedPath

The Comparison of Single and Multi-incision MIE for Esophageal Cancer

Not Applicable
Conditions
Esophageal Cancer
Interventions
Procedure: Minimally invasive esophagectomy
Registration Number
NCT03646110
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Minimally invasive esophagectomy (MIE) has been gradually adopted as a feasible and effective treatment option for esophageal cancer. Previously the investigators have published the adoption of single-incision approach both in the thoracoscopic and laparoscopic phases in MIE (SIMIE).The preliminary clinical results showed that SIMIE can provide an equivalent perioperative outcome whereas reduced the wound pain on the days 7 after surgery as compared to MIE performed with multi-incision (MIMIE). The goal of the current study was to conduct a prospective randomized trial to compare the perioperative outcome and survival of SIMIE and MIMIE.

Detailed Description

Surgery remains the main stay of treating esophageal cancer. However, esophagectomy is a complex and technical demanding surgical procedure harboring substantial morbidity and mortality. Minimally invasive esophagectomy (MIE) has been gradually adopted as a feasible and effective treatment option for esophageal cancer. The standardized procedure including lymph node dissection, esophageal mobilization and reconstruction can be effectively performed under minimized wound incision whereas rendering the patients a possibility of faster postoperative recovery and reduced risk of perioperative postoperative pulmonary complication. The procedure of MIE including the thoracoscopic and laparoscopic phases which are usually performed multiple incisional wounds. Previously the investigators have published the adoption of single-incision approach both in the thoracoscopic and laparoscopic phases in MIE (SIMIE). The preliminary clinical results showed that SIMIE can provide an equivalent perioperative outcome whereas reduced the wound pain on the days 7 after surgery as compared to MIE performed with multi-incision (MIMIE). The goal of the current study was to conduct a prospective randomized trial to compare the perioperative outcome and survival of SIMIE and MIMIE.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Patients with a diagnosis of esophageal cancer
  2. Age between 35 to 75 years old
  3. Resectable tumor as evaluation by preoperative imaging studies.
Read More
Exclusion Criteria
  1. Previous surgery in the chest or abdomen.
  2. Receiving definitive chemoradiation (5500 cGy or more).
  3. Tumor invasion to the trachea, spine or aorta.
  4. Liver cirrhosis with esophageal varices or liver cirrhosis refractory to medical treatment, Child C classification.
  5. Previous history of cerebral vascular attack.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
single-incision MIEMinimally invasive esophagectomyEsophageal cancer patients received single-incision Minimally invasive esophagectomy
multi-incision MIEMinimally invasive esophagectomyEsophageal cancer patients received multi-incision Minimally invasive esophagectomy
Primary Outcome Measures
NameTimeMethod
Overall survival rate60 months

Overall survival rate of the participants after surgery

Secondary Outcome Measures
NameTimeMethod
Ratio of ambulationpost-operative day 2 (POD2)

30-minute walk test

Pain score as assessed by the face rating scale1,7,14,28 days

The scale range of face rating scale is ranging from 0 (happy face) to 10 (crying face). Higher values represent a worse outcome.

Postoperative force vital capacity1 and 3 months

Force vital capacity (FVC) is one of the most common parameters for pulmonary function measured in spirometry

Post operative forced expiratory volume in one second1 and 3 months

Forced expiratory volume in one second (FEV1) is one of the most common parameters for pulmonary function measured in spirometry

Postoperative pulmonary complication1 month

pulmonary complication after esophagectomy

Trial Locations

Locations (1)

Jang-Ming Lee

🇨🇳

Taipei City, Zhongzheng Dist., Taiwan

© Copyright 2025. All Rights Reserved by MedPath